Access Abiraterone Acetate-famed in the pharmaceutical industry for its role in treating prostate cancer. This renowned compound, also known as Zytiga or CB7630, is a white to off-white powder, celebrated for favorable reviews among medical professionals. Its enlightened formulation offers pharmaceutical intermediates suited for advanced therapies. Get it now from a trusted exporter, importer, manufacturer, and supplier based in India. With a shelf life of 2 years, it's packaged securely in double PE bags and HDPE drums. Soluble in DMSO and methanol, this product is practically insoluble in water.
Premier Use in Oncology Medicines
Abiraterone Acetate serves as a vital pharmaceutical intermediate, specifically used in the treatment of prostate cancer. Its primary application is within oncology, where it supports advanced medical treatments. The site of application is typically clinical settings, managed by healthcare professionals dedicated to cancer care. This product's specific usage ensures effective intervention in hormone-related prostate cancers, making it indispensable in cancer therapy protocols. Its significance continues to grow in the global oncology landscape.
Certified Quality & Robust Packaging Standards
Abiraterone Acetate is supplied with relevant pharmaceutical certifications, assuring consistent quality and compliance. Packaging involves secure double PE bags, further protected by HDPE drums, ensuring safe transit and long shelf life. A purchase order confirms your request, initiating a streamlined supply process. The product's market value is increasingly recognized, especially across the Indian main domestic market, where demand remains high for certified, reliable pharmaceutical intermediates supporting cancer treatment.
Premier Use in Oncology Medicines
Abiraterone Acetate serves as a vital pharmaceutical intermediate, specifically used in the treatment of prostate cancer. Its primary application is within oncology, where it supports advanced medical treatments. The site of application is typically clinical settings, managed by healthcare professionals dedicated to cancer care. This product's specific usage ensures effective intervention in hormone-related prostate cancers, making it indispensable in cancer therapy protocols. Its significance continues to grow in the global oncology landscape.
Certified Quality & Robust Packaging Standards
Abiraterone Acetate is supplied with relevant pharmaceutical certifications, assuring consistent quality and compliance. Packaging involves secure double PE bags, further protected by HDPE drums, ensuring safe transit and long shelf life. A purchase order confirms your request, initiating a streamlined supply process. The product's market value is increasingly recognized, especially across the Indian main domestic market, where demand remains high for certified, reliable pharmaceutical intermediates supporting cancer treatment.
FAQ's of Abiraterone Acetate:
Q: How should Abiraterone Acetate be stored to maintain its efficacy?
A: Abiraterone Acetate should be stored under recommended conditions in tightly sealed packaging, ideally in a cool, dry place, ensuring its shelf life of up to 2 years.Q: What are the main applications of Abiraterone Acetate?
A: It is primarily used as a pharmaceutical intermediate in the treatment of prostate cancer, particularly in oncology clinics and hospitals.Q: When can I place a purchase order and what is the supply process?
A: Purchase orders can be placed at any time via the supplier. Once received, the order is processed and supplied according to the specified packaging standards to ensure safe delivery.Q: Where is Abiraterone Acetate mainly marketed and supplied?
A: The product is primarily marketed and supplied across the Indian main domestic market, supported by certified exporters and suppliers.Q: What are the benefits of using Abiraterone Acetate in prostate cancer treatment?
A: Abiraterone Acetate is renowned for its effectiveness in inhibiting androgen production, offering improved outcomes for patients with hormone-dependent prostate cancer.
© Copyright 2023 Hema Pharma. All Rights Reserved Copyright